Mobile Site ›

Test Catalog

Test ID: MSH2K    
MSH2 Known Mutation

NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.


Useful For Suggests clinical disorders or settings where the test may be helpful

Diagnostic or predictive testing for Lynch syndrome/hereditary nonpolyposis colorectal cancer when an MSH2 or EPCAM mutation has been identified in a family member

Testing Algorithm Delineates situation(s) when tests are added to the initial order. This includes reflex and additional tests.


Special Instructions and Forms Describes specimen collection and preparation information, test algorithms, and other information pertinent to test. Also includes pertinent information and consent forms to be used when requesting a particular test

Method Name A short description of the method used to perform the test

Polymerase Chain Reaction (PCR)/DNA Sequencing or Dosage Analysis (multiplex ligation-dependent probe amplification [MLPA] or Southern blot analysis) is utilized to test for the presence of a specific mutation previously identified in an affected family member.
(PCR is utilized pursuant to a license agreement with Roche Molecular Systems, Inc.)

Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name

MSH2 Known Mutation

Aliases Lists additional common names for a test, as an aid in searching

Colon Cancer gene testing
Hereditary Nonpolyposis Colorectal Cancer (HNPCC)
hMSH2 genotyping
HNPCC (Hereditary Nonpolyposis Colorectal Cancer) gene testing
Lynch Syndrome
MSH2 gene testing